Literature DB >> 1906461

High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan.

S Narindrasorasak1, D Lowery, P Gonzalez-DeWhitt, R A Poorman, B Greenberg, R Kisilevsky.   

Abstract

High affinity interactions were studied between the basement membrane form of heparan sulfate proteoglycan (HSPG) and the 695-, 751-, and 770-amino acid Alzheimer amyloid precursor (AAP) proteins. Based on quantitative analyses of binding data, we identified single binding sites for the HSPG on AAP-695 (Kd = 9 x 10(-10) M), AAP-751 (Kd = 10 x 10(-9) M), and AAP-770 (Kd = 9 x 10(-9) M). It is postulated that the "Kunitz" protease inhibitor domain which is present in AAP-751 and -770 reduces the affinity of AAPs for the HSPG through steric hindrance and/or conformational alteration. HSPG binding was inhibited by heparin and dextran sulfate, but not by dermatan or chondroitin sulfate. HSPG protein core, obtained by heparitinase digestion, also bound to the beta-amyloid precursor proteins with high affinity, indicating that the high affinity binding site is constituted by the polypeptide chain rather than the carbohydrate moiety. The effects of various cations on these interactions were also studied. Our results suggest that specific interactions between the AAP proteins and the extracellular matrix may be involved in the nucleation stages of Alzheimer's disease type amyloidogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 2.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

3.  Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix.

Authors:  A D Murdoch; R V Iozzo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.

Authors:  L Buée; P R Hof; C Bouras; A Delacourte; D P Perl; J H Morrison; H M Fillit
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells.

Authors:  Robert Kisilevsky; Ian Crandall; Walter A Szarek; Shridhar Bhat; Christopher Tan; Lee Boudreau; Kevin C Kain
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 6.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

7.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09

8.  Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.

Authors:  G Perry; P L Richey; S L Siedlak; M A Smith; P Mulvihill; D A DeWitt; J Barnett; B D Greenberg; R N Kalaria
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

Review 9.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

10.  Systematic evaluation of candidate ligands regulating ectodomain shedding of amyloid precursor protein.

Authors:  Heather C Rice; Tracy L Young-Pearse; Dennis J Selkoe
Journal:  Biochemistry       Date:  2013-05-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.